Skip to main content
. 2021 Jul 17;11(7):2129. doi: 10.3390/ani11072129

Figure 1.

Figure 1

The hepatoprotective efficacy of nanosilica in different doses: (a) control normal group hepatic samples with normal morphological features of the hepatic parenchyma, (b) hepatic samples of nanosilica in the 0.05% administrated group, (c) hepatic samples of nanosilica in the 0.10% administrated group, (d) hepatic samples of nanosilica in the 0.15% administrated group, (e) hepatic samples of nanosilica in the 0.20% administrated group, and (f) hepatic samples of nano-bentonite administrated group. H&E stain. X400. Scale bar: 50 microns.